Immunocore Holdings (IMCR) Debt Ratio (2019 - 2026)

Immunocore Holdings (IMCR) posted quarterly Debt Ratio of 0.37 for Q1 2026, down 3.59% year-on-year from 0.38 in Q1 2025, and little changed on a QoQ basis from 0.37 in Q4 2025.

Immunocore Holdings (IMCR) Debt Ratio (2019 - 2026) Analysis & Trends

Immunocore Holdings (IMCR) has reported Debt Ratio for 8 consecutive years, with 0.37 the latest figure, recorded in Q1 2026.

  • Quarterly Debt Ratio fell 3.59% year-over-year to 0.37 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.37 (down 3.59% YoY) and the FY2025 annual result came in at 0.37, down 4.9% from the prior year.
  • Debt Ratio was little changed at 0.37 in Q1 2026 per IMCR's latest filing, from 0.37 in the prior quarter.
  • Over the last five years, Debt Ratio for IMCR reached as high as 0.44 in Q1 2024 and fell as low as 0.08 in Q4 2023.
  • A 5-year average of 0.3 and a median of 0.37 in 2026 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2022 — Debt Ratio fell 26.48% — and 2024, when it soared 394.73%.
  • Year by year, Debt Ratio stood at 0.09 in 2022, then declined by 11.33% to 0.08 in 2023, then soared by 381.63% to 0.39 in 2024, then decreased by 4.9% to 0.37 in 2025, then fell by 0.31% to 0.37 in 2026.
  • According to Business Quant data, Debt Ratio over the past three periods registered 0.37, 0.37, and 0.36 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immunocore Holdings 1.80 Bn 957.43 Mn 106.24 Mn 0.37

Historic Data

Download Data
DateValue
Mar 31, 2026 0.37
Dec 31, 2025 0.37
Sep 30, 2025 0.36
Jun 30, 2025 0.36
Mar 31, 2025 0.38
Dec 31, 2024 0.39
Sep 30, 2024 0.40
Jun 30, 2024 0.43
Mar 31, 2024 0.44
Dec 31, 2023 0.08
Jun 30, 2023 0.09
Dec 31, 2022 0.09
Sep 30, 2022 0.10
Dec 31, 2021 0.12
Dec 31, 2020 0.19
Dec 31, 2019 0.10